Cargando…

Prognostic value of modified-Gustave-Roussy Immunity Score in resectable proximal gastric cancer

The prognostic evaluation of GRIm score has been confirmed in many tumor species. The purpose of this study is to clarify the value of GRIm score in the prognostic evaluation of patients with resectable proximal gastric cancer. A single center retrospective study was conducted in 174 patients with p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Yujing, Ju, Mengyang, Di, Xiaoke, Sun, Xinchen, Chen, Xiaojiao, He, Chenhong, Liang, Liang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	4500
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10036012/ https://www.ncbi.nlm.nih.gov/pubmed/36961166 http://dx.doi.org/10.1097/MD.0000000000033334

Ejemplares similares

Gustave Roussy Immune Score (GRIm-Score) is a prognostic marker in patients with resectable esophageal squamous cell carcinoma
por: Feng, Ji-Feng, et al.
Publicado: (2020)

Prognostic significance of the Gustave Roussy immune (GRIm) score in cancer patients: a meta-analysis
por: Sun, Ke-Xin, et al.
Publicado: (2023)

Bilateral germ-cell tumours: 22-year experience at the Institut Gustave Roussy
por: Theodore, Ch, et al.
Publicado: (2004)

Feasibility and first reports of the MATCH-R repeated biopsy trial at Gustave Roussy
por: Recondo, Gonzalo, et al.
Publicado: (2020)

Development and Validation of a Prognostic Score for Hepatocellular Carcinoma Patients in Immune Checkpoint Inhibitors Therapies: The Hepatocellular Carcinoma Modified Gustave Roussy Immune Score
por: Li, Yongjiang, et al.
Publicado: (2022)

Gustave Roussy Immune Score as a Novel Prognostic Scoring System for Colorectal Cancer Patients: A Propensity Score Matching Analysis
por: Tian, Shan, et al.
Publicado: (2021)

Gustave Roussy Immune Score and Royal Marsden Hospital Prognostic Score Are Prognostic Markers for Extensive Disease of Small Cell Lung Cancer
por: Minami, Seigo, et al.
Publicado: (2020)

The hepatocellular carcinoma modified Gustave Roussy Immune score (HCC‐GRIm score) as a novel prognostic score for patients treated with atezolizumab and bevacizumab: A multicenter retrospective analysis
por: Hatanaka, Takeshi, et al.
Publicado: (2022)

Gustave Roussy Immune Score and Royal Marsden Hospital Prognostic Score Are Biomarkers of Immune-Checkpoint Inhibitor for Non-Small Cell Lung Cancer
por: Minami, Seigo, et al.
Publicado: (2019)

1688P Outcome of older cancer patients infected with COVID-19 at Gustave Roussy Cancer Center
por: Hauchecorne, M., et al.
Publicado: (2020)

Gustave Roussy Immune Score Is a Prognostic Factor for Chemotherapy-Naive Pulmonary Adenocarcinoma With Wild-Type Epidermal Growth Factor Receptor
por: Minami, Seigo, et al.
Publicado: (2019)

Impact of missing individual patient data on 18 meta-analyses of randomised trials in oncology: Gustave Roussy experience
por: Fayard, Florence, et al.
Publicado: (2018)

Helping patients make informed decisions. Two-year evaluation of the Gustave Roussy prostate cancer multidisciplinary clinic
por: Patrikidou, Anna, et al.
Publicado: (2018)

Gustave Roussy immune score is a prognostic marker in patients with small cell lung cancer undergoing immunotherapy: a real-world retrospective study
por: Shangguan, Jian, et al.
Publicado: (2023)

Aberrant brain-expressed X-linked 4 (BEX4) expression is a novel prognostic biomarker in gastric cancer
por: Zhu, Chenhong, et al.
Publicado: (2020)

Cardiac abnormalities 15 years and more after adriamycin therapy in 229 childhood survivors of a solid tumour at the Institut Gustave Roussy
por: Pein, F, et al.
Publicado: (2004)

41P The SARS-CoV-2 vaccine and enrollment of patients with cancer in phase I trials: The experience at Institute Gustave Roussy
por: Belcaid, L., et al.
Publicado: (2022)

Evaluation and validation of the prognostic value of nutrition and immunity parameters in gastric cancer after R0 resection
por: Xue, Wenbo, et al.
Publicado: (2020)

Prognostic Value of the Modified Glasgow Prognostic Score in Patients Undergoing Radical Surgery for Hepatocellular Carcinoma
por: Ni, Xiao-Chun, et al.
Publicado: (2015)

The Gustave Roussy Immune (GRIm)-Score Variation Is an Early-on-Treatment Biomarker of Outcome in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Treated with First-Line Pembrolizumab
por: Lenci, Edoardo, et al.
Publicado: (2021)

Short- and Long-Term Outcomes of Laparoscopic Versus Open Resection for Gastric Gastrointestinal Stromal Tumors: A Propensity Score-Matching Analysis
por: Chen, Qing-Feng, et al.
Publicado: (2016)

Proximal gastrectomy with double-tract reconstruction versus total gastrectomy for proximal early gastric cancer: A systematic review and meta-analysis
por: Xiang, Renshen, et al.
Publicado: (2021)

Endoscopic Resection Versus Surgical Resection for Early Gastric Cancer: A Systematic Review and Meta-Analysis
por: Sun, Weili, et al.
Publicado: (2015)

Risk Factors for Gallstone Formation in Resected Gastric Cancer Patients
por: Paik, Kyu-hyun, et al.
Publicado: (2016)

The prognostic value of preoperative inflammation-based prognostic scores and nutritional status for overall survival in resected patients with nonmetastatic Siewert type II/III adenocarcinoma of esophagogastric junction
por: Zhang, Lixiang, et al.
Publicado: (2017)

Endoscopic Versus Open Resection for Small Gastric Gastrointestinal Stromal Tumors: Safety and Outcomes
por: Shen, Chaoyong, et al.
Publicado: (2015)

Systematic review of partial hepatic resection to treat hepatic metastases in patients with gastric cancer
por: Long, Di, et al.
Publicado: (2016)

Application Value of a 6-Type Classification System for Common Hepatic Artery Absence During Laparoscopic Radical Resections for Gastric Cancer: A Large-Scale Single-Center Study
por: Huang, Chang-Ming, et al.
Publicado: (2015)

Impact d’un test de diagnostic du coronavirus positif sur le parcours du patient en radiothérapie à l’institut Gustave-Roussy
por: Chiesa, V., et al.
Publicado: (2022)

Risk factors and clinical outcomes of postgastrectomy sarcopenia newly developed after curative resection for gastric cancer
por: Kim, Hye Jin, et al.
Publicado: (2022)

Hepatic resection or transarterial chemoembolization for hepatocellular carcinoma within Milan criteria: A propensity score matching analysis
por: Guo, Zhe, et al.
Publicado: (2017)

Clinicopathological characteristics of patients who underwent additional gastrectomy after incomplete endoscopic resection for early gastric cancer
por: Hwang, Jae Jin, et al.
Publicado: (2017)

Mind the tributary of the canal: Are stents necessary for insulinoma enucleation in proximity to a prominent Duct of Santorini: A case report and literature review
por: Liu, Tiantong, et al.
Publicado: (2022)

The analysis of prognostic factors of primary small intestinal gastrointestinal stromal tumors with R0 resection: A single-center retrospective study
por: Qu, Hui, et al.
Publicado: (2022)

Value of Magnifying Endoscopy With Narrow-Band Imaging and Confocal Laser Endomicroscopy in Detecting Gastric Cancerous Lesions
por: Gong, Shuai, et al.
Publicado: (2015)

Clinical significance of ubiquilin 1 in gastric cancer
por: Bao, Jingjing, et al.
Publicado: (2018)

Why the Proximal Splenic Artery Approach is the Ideal Approach for Laparoscopic Suprapancreatic Lymph Node Dissection in Advanced Gastric Cancer? A Large-Scale Vascular-Anatomical-Based Study
por: Chen, Rui-Fu, et al.
Publicado: (2015)

A case report of endoscopic resection for the treatment of duodenal Brunner's gland adenoma with upper gastrointestinal bleeding
por: Liang, Ma, et al.
Publicado: (2020)

Inflammation-nutrition scope predicts prognosis of early-stage hepatocellular carcinoma after curative resection
por: Zhu, Ying, et al.
Publicado: (2017)

Low Discrepancy Between Tissue Biopsy Plus Magnifying Endoscopy With Narrow-Band Imaging and Endoscopic Resection in the Diagnosis of Gastric Epithelial Neoplasia (STROBE)
por: Zhang, Qiang, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_mm7qf8m44jfp973ghee7ifjr98